Journal Reviews
Ocular sequalae of spinal muscular atrophy
The authors present a retrospective single-centre cohort study of patients with spinal muscular atrophy – a neurodegenerative disorder presenting between infancy and early adulthood. Forty-eight patients were included in total, with roughly equal numbers of types 1, 2 and 3...
Quality of Instagram posts about amblyopia
The purpose of this study was to better understand the availability, accuracy and extent of information available on Instagram about amblyopia. The authors evaluated content of the top 200 publicly available Instagram posts about amblyopia from October–December 2022. Posts were...
Visual acuity improvement in amblyopic eyes following fellow eye vision loss
The authors present a systematic review with the aim of reporting how frequently and to what extent amblyopia recovers following the loss of vision in the fellow eye and identify any potential clinical predictors. Studies including adults with amblyopia and...
How does presentation, progression and outcome of new onset diplopia vary between older and younger adults?
The authors present a retrospective case review with the aim of comparing the frequency of different causes for new onset binocular diplopia in 2 age groups, above and below 65 years old. Adult patients with new onset diplopia within a...
Hypothesis for poor visual outcomes in myeline oligodendrocyte glycoprotein-related optic neuritis after first attack
The authors present a retrospective case review with the aim of describing the group of patients with myelin-oligodendrocyte glycoprotein-associated optic neuritis (MOG-ON) who had poor visual outcomes following their first attack despite rapid treatment. The study was conducted at a...
Aetiology of painful ophthalmoplegia
Painful ophthalmoplegia is a clinical syndrome presenting with periorbital / hemi-cranial pain and ipsilateral ocular motor nerve palsies and can occur with numerous different diseases. In this study, the authors aimed to determine the final definite aetiology among patients with...
How common are carotid-cavernous fistulas and what are the neuro-ophthalmic manifestations?
The authors present a retrospective study using the Rochester Epidemiology Project database. The aim was to establish the incidence of carotid-cavernous fistulas (CCF) and outline the associated neuro-ophthalmic patterns. Cases were identified from the database using the following criteria: a...
Photophobia associated with migraine: Investigating associations with productivity
The aim of this study was to investigate an association between severe photophobia linked to migraine and reduced work productivity. Cases were extracted from the American Registry for Migraine Research (ARMR) with the following criteria: diagnosed with migraine, data available...
Developing a data registry for neuro-ophthalmology with quality assurance measures
The authors aimed to report the scope of neuro-ophthalmology clinics in Australia, referral patterns and develop a quality assurance framework for referrals. Cases were identified from a single tertiary neuro-ophthalmology centre. Data was prospectively collected into the National Neuro-ophthalmology Database...
Which cover test method is the best starting point for prescribing temporary prisms?
A retrospective review of medical records was completed, identifying consecutive patients prescribed Fresnel prisms for diplopia, assessed using both simultaneous prism and cover test (SPCT) and prism and alternate cover test (PACT) by a single orthoptist over a 36-month period....
Comparison of MRI finding in oculomotor cranial nerve palsies as a result of inflammation and ischaemia
This study aimed to explore the value of asymmetric enhancement of the cavernous sinus on MRI for differential diagnosis between ocular myasthenia gravis, ischemic or inflammatory oculomotor cranial nerve palsies. Three groups were recruited consecutively over a 30-month period and...
Oxymetazoline hydrochloride for improved symmetry in Graves’ disease
Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial alpha 2 agonist that stimulates Muller’s muscle to lift the lid. The authors of this...
